Johns Hopkins

 

Johns Hopkins
A

Output From the National MDS Study: Utility of Targeted Gene Sequencing to Differentiate Myeloid Malignancies From Other Cytopenic Conditions

By Johns Hopkins FEATURING Amy DeZern
By Johns Hopkins FEATURING Amy DeZern
205 views
June 7, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Videos
20:07

New

BRAF/MEK Targeted Therapy in Adult and Pediatric Glioma: Insights an…

Johns Hopkins

K. Schreck

44 views
07:41

Impact of Neoadjuvant IO on Recurrence-Free Survival in High-Risk Lo…

Johns Hopkins

M. Nakazawa

103 views
15:57

ASCO® 2024 Summary: "Treatment Strategies and QoL Impact in mCRPC - …

2024 ASCO® Annual Meeting Insights Hub

C. Paller

172 views
11:47

Current Evidence for Frontline Systematic Treatment in Advanced HCC

Johns Hopkins

M. Baretti

273 views
08:11

ASH 2023 Insights: "A Comparison of HMAs Combined With Ivosidenib or…

Insights from 2023 ASH Annual Meeting

A. Ambinder

50 views
13:15

Output From the National MDS Study: Utility of Targeted Gene Sequenc…

Johns Hopkins

A. DeZern

205 views
16:27

Targeting BRAF-Altered Glioma in Adults

Johns Hopkins

K. Schreck

455 views
15:49

Severe Aplastic Anemia: What's on the Horizon?

Johns Hopkins

A. DeZern

561 views
09:23

Advancements in Systemic Therapy for Advanced HCC: Where Are We Going

Johns Hopkins

M. Yarchoan

671 views
34:01

Latest Treatment Strategies and Standard of Care for Pancreatic Canc…

MedNews Week

M. Pishvaian

629 views
21:21

KRASG12C Mutation in NSCLC: Current Data and Future Directions

Johns Hopkins

S. Rosner

448 views